The urokinase-type plasminogen activator (uPA) receptor (uPAR) and its ligand uPA are involved in numerous physiological and pathological processes including pericellular proteolysis, wound healing, tissue regeneration and tumor progression [
1‐
3]. The uPAR protein belongs to the Ly-6/uPAR/α-neurotoxin protein domain family [
4] and is a single chain three-domain glycoprotein designated DI, DII and DIII [
5]. Since uPAR is located on the cell surface by a glycosyl phosphatidylinositol (GPI) anchor and lacks a trans-membrane domain, it needs to interact with other partner proteins including integrins to activate cellular signaling pathways [
6‐
8]. There also exist three soluble forms of uPAR, DI, DIDII and DIDIIDIII, which are present in cancer cells, urine, blood and cerebrospinal fluid [
9‐
12]. uPAR expression is up-regulated during inflammation [
13] and many other diseases [
14] including cancer, and its expression levels correlate with poor prognosis [
15‐
18]. uPA binds to uPAR and converts the zymogen plasminogen into plasmin which promotes degradation of ECM by direct digestion and activation of pro-matrix metalloproteases (MMPs), including MMP-2, -9, -12 and -13 [
19]. In addition to the binding of uPA, uPAR initiates signal transduction pathways by interacting with other molecules such as vitronectin, integrins β1/2/3, cytokeratin 8/18 and EGFR (epidermal growth factor receptor) [
1,
20]. These interactions with uPAR result in various functional consequences depending on the specific interacting protein. For example, vitronectin binds to uPAR, and once phosphorylated, regulates uPAR-dependent cell adhesion [
8,
21,
22]. However, to date, the numerous and varied roles of uPAR in cell adhesion, migration, proliferation, angiogenesis and cancer metastasis are not completely explained by identified known protein interactions. We therefore speculate that there are still additional and as yet unidentified uPAR partners. Recently we have described an uPAR binding protein, heat shock protein MRJ, which can regulate uPAR-mediated cell adhesion to vitronectin [
23]. In this paper, we identified another heat shock protein HSP70 which can also interact with uPAR.
Heat shock proteins (HSPs) are a set of highly conserved proteins that are inducible by a wide variety of physiological and environmental factors including anti-cancer chemotherapy, thus allowing the cells to survive to lethal conditions. The HSP70 protein is a member of the DnaK/HSP70 class (HSP701A1, 72KDa) (NM_005345). The MRJ protein is member 6 of the DnaJ/HSP40 homolog subfamily B (DnaJB6) (NM_005494). MRJ is an essential co-chaperone of HSP70, with the N-terminal J-domain necessary for its interaction with HSP70 and its chaperone activity [
24,
25]. MRJ drives the substrate specificity of HSP70. They usually cooperate in the binding of proteins at intermediate stages of folding, assembly, and translocation across membranes in almost all cellular compartments. Similar to uPAR, expression levels of HSP70 and MRJ are correlated with metastasis and poor prognosis in breast cancer cells [
26]. To date, little is known about interaction of HSP70/MRJ complex with uPAR and the biological significance of HSP70/MRJ complex in regulation of uPAR and its signaling. To answer these questions, we show here that the heat shock proteins HSP70 and MRJ form a triple complex and interact functionally with uPAR to increase uPAR-mediated cell migration and adhesion to vitronectin.